Intrinsic Value of S&P & Nasdaq Contact Us

Marpai, Inc. MRAI OTC

Other OTC • Healthcare • Medical - Healthcare Plans • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+2042.9%

Marpai, Inc. (MRAI) has a consensus analyst rating of Buy, based on 1 analyst covering the stock. Of those, 1 recommend buying, 0 recommend holding, and 0 recommend selling.

The analyst consensus price target for MRAI is $6.00, representing a +2,042.9% upside from the current price of $0.28. Price targets range from a low of $6.00 to a high of $6.00.

Analyst Consensus — MRAI

Buy
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts
Price Targets
Consensus$6.00
High$6.00
Low$6.00
Median$6.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message